Login to Your Account



NewCo News

Gradalis Emerges from Stealth With Phase II Cancer Vaccine

By Trista Morrison
Staff Writer

Thursday, March 15, 2012
Cancer vaccines, long the red-headed stepchildren of biotech, were briefly catapulted into the limelight by Dendreon Corp.'s 2010 approval of Provenge (sipuleucel-T) only to be dragged back down by that drug's disappointing sales.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription